Rituximab

186,00 211,00 

Therapeutic CD20-antibody from the original Mabthera commercial drug targeting the CD20-antigen, also referred to as Mabthera antibody.

Category Product Concentration [mg/mL] Volume per Vial [µL] Quantity per vial [mg] Batch Number Storage [°C] Original therapeutic expiry date [see Note 1] CoA [see Note 2] PriceQuantityTotal
aliquot102002H0203B05-80°05/2018no 186,00 
-
+
186,00 
spinner
aliquot102002H0209B04-80°09/2018no 186,00 
-
+
186,00 
spinner
aliquot102002N7129B16-80°12/2018no 186,00 
-
+
186,00 
spinner
aliquot102002N7135B18-80°02/2019no 186,00 
-
+
186,00 
spinner
aliquot102002N7135B11-80°02/2019no 186,00 
-
+
186,00 
spinner
aliquot102002N7174B06-80°08/2019no 186,00 
-
+
186,00 
spinner
aliquot102002N7190B08-80°12/2019no 186,00 
-
+
186,00 
spinner
aliquot102002N7321B382-8°/-80°07/2021no 211,00 
-
+
211,00 
spinner
aliquot102002N7438B092-8°/-80°02/2023yes 211,00 
-
+
1.055,00 
spinner

Description

Additional information

Category

aliquot, dilution

Therapeutic molecule

Rituximab

Antigen

CD20

Product Concentration [mg/mL]

1, 10

Volume per Vial [µL]

100, 200

Quantity per vial [mg]

0, 0,1, 2

Batch Number

NOT APPLICABLE, H0209B04, N7129B16, N7135B18, N7174B06, N7190B08, -, H0203B05, N7135B11, N7321B38, N7438B09

Storage [°C]

-, -80°, 2-8°/-80°

Original therapeutic expiry date [see Note 1]

02/2023, 07/2021, -, 02/2019, 05/2018, 08/2019, 09/2018, 12/2018, 12/2019, NOT APPLICABLE

CoA [see Note 2]

no, yes

You may also like…